Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer
Self Efficacy
Enrolment: 100 · Results not recorded
Loading the evidence…
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Self Efficacy
Enrolment: 100 · Results not recorded
Stage I Hepatocellular Carcinoma · Stage II Hepatocellular Carcinoma
Enrolment: 480 · Results not recorded
Hepatocellular Carcinoma
Enrolment: 320 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute omethoate (organophosphate) poisoning induced lung injury, omethoate given subcutaneously as a single 60 mg/kg dose
Ginsenoside Rg3 attenuated omethoate-induced lung injury, increasing lung glutathione (p less than 0.05 or p less than 0.01), ameliorating the altered activities of superoxide dismutase and catalase (p less than 0.05 or p less than 0.01) and significantly reducing malondialdehyde, TNF-alpha and mye…
Extraction: extract · Supplied extraction confidence: 0.72. Machine-extracted fields require source verification.